Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,518.80
(
-0.01%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
98.46
(
1.72%
)
Bitcoin
71,265.00
(
0.51%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 118186

Thursday, 06/27/2013 5:42:34 PM

Thursday, June 27, 2013 5:42:34 PM

Post# of 257273
FDA approves BAX’s recombinant Factor-IX, called Rixubis:

http://finance.yahoo.com/news/fda-approves-baxter-rixubis-first-130000420.html

Rixibus competes with PFE’s Benefix; both are IV preparations, but only Rixibus is indicated for semi-weekly administration for prophylaxis.

BIIB plans to enter this market too (#msg-42643715, #msg-62038760).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up